Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

Navita Clocks and Bone Marrow Fibrosis

navita clocks two rucksolitinib in people who are terra pinaiv. 35% volumetric reduction in spleen there was some improvement in the symptoms as well one issue with this drug navita clocks is which is vcl2 and vclxinibitinib it's not that simple. early intervention with the best combination so one approach is here to add navita clocks  to a face three study underway.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app